Latest Nanexa News & Updates

See the latest news and media coverage for Nanexa. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Nanexa

Developer of long-acting injectable drug delivery systems

nanexa.com
Headquarters
Uppsala, Sweden
Founded year
2007
Company type
Public company
Number of employees
25–50

Last updated

Latest news about Nanexa

In short: Nanexa advanced its PharmaShell platform through strong preclinical results for semaglutide and a major licensing agreement with Moderna.

Company announcements

Nanexa

Nanexa resolves on set-off of SEK 20 million loan

The Board issues shares and warrants to lenders, converting debt to equity, strengthening the balance sheet and preserving liquidity. Dilution is approximately 3.27% from shares and up to 6.34% total.

Nanexa

Nanexa issues notice of annual general meeting

The meeting occurs on 12 May 2026 at 3:00 pm in Uppsala, Sweden. Shareholders must register by 7 May 2026. Agenda includes financial statements, board elections, and share issue authorizations.

Unlock all announcements with a

Media coverage

London Stock Exchange

Nanexa publishes annual report for 2025

Nanexa AB (publ) today announces that the Annual Report for 2025 has been published and is available on the company's website Nanexa AB - Financial...

London Stock Exchange

Nanexa Announces Breakthrough Preclinical Data Demonstrating Exceptional Pharmacokinetic Profile for Monthly Semaglutide Formulation

Nanexa's atomic layer deposition (ALD) platform PharmaShell® demonstrably improves the pharmacokinetic profile of semaglutide injections.Significantly smoother plasma concentration curve could mitigate many common side effects...

Unlock all articles with a

Never miss news about Nanexa

Track Nanexa and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Nanexa competitors & trending companies

Browse news for competitors to Nanexa and other trending companies.